ScholarIQanswers from OpenAlex

Neoadjuvant chemotherapy response and genetic susceptibility in recently parous women with breast cancer

PaperCitations, authors & open-access status

Neoadjuvant chemotherapy response and genetic susceptibility in recently parous women with breast cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Neoadjuvant chemotherapy response and genetic susceptibility in recently parous women with breast cancer have?

ScholarIQcitation count

Neoadjuvant chemotherapy response and genetic susceptibility in recently parous women with breast cancer has 0 citations in the OpenAlex counts ScholarIQ stores.

When was Neoadjuvant chemotherapy response and genetic susceptibility in recently parous women with breast cancer published?

ScholarIQyear

Neoadjuvant chemotherapy response and genetic susceptibility in recently parous women with breast cancer has 2025 year in the ScholarIQ index.

What is the open-access status of Neoadjuvant chemotherapy response and genetic susceptibility in recently parous women with breast cancer?

ScholarIQoa status

Neoadjuvant chemotherapy response and genetic susceptibility in recently parous women with breast cancer has green oa status in the ScholarIQ index.

What is the DOI of Neoadjuvant chemotherapy response and genetic susceptibility in recently parous women with breast cancer?

ScholarIQdoi

The DOI for Neoadjuvant chemotherapy response and genetic susceptibility in recently parous women with breast cancer is on the source record.

What is the PMID of Neoadjuvant chemotherapy response and genetic susceptibility in recently parous women with breast cancer?

ScholarIQpmid

The PMID for Neoadjuvant chemotherapy response and genetic susceptibility in recently parous women with breast cancer is on the source record.

What is the OpenAlex record for Neoadjuvant chemotherapy response and genetic susceptibility in recently parous women with breast cancer?

ScholarIQopenalex

The OpenAlex for Neoadjuvant chemotherapy response and genetic susceptibility in recently parous women with breast cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial